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A B S T R A C T
Noninvasive MR-guided focused ultrasound (MRgFUS) treatments are promising alter-
natives to the surgical removal of malignant tumors. A significant challenge is assessing
the treated tissue immediately after MRgFUS procedures. Although current clinical as-
sessment uses the immediate nonperfused volume (NPV) biomarker derived from con-
trast enhanced imaging, the use of contrast agent prevents continuing MRgFUS treat-
ment if margins are not adequate. In addition, the NPV has been shown to provide
variable accuracy for the true treatment outcome as evaluated by follow-up biomarkers.
This work presents a novel, noncontrast, learned multiparametric MR biomarker that
is conducive for intratreatment assessment. MRgFUS ablations were performed in a
rabbit VX2 tumor model. Multiparametric magnetic resonance images were obtained
both during and immediately after the MRgFUS ablation, as well as during follow-up
imaging obtained 3-5 days after the ablation treatment. Expert segmentation of the NPV
obtained during follow-up imaging was used to train a deep convolutional neural net-
work on noncontrast multiparametric MR images. The NPV follow-up segmentation
was registered to treatment-day images using a novel volume-conserving registration
algorithm, allowing a voxel-wise correlation between imaging sessions. Contrasted
with state-of-the-art registration algorithms that change the average volume by 16.8%,
the presented volume-conserving registration algorithm changes the average volume by
only 0.28%. Using the registration results, the learned multiparametric MR biomarker,
consisting of temperature, T2-weighted, and apparent diffusion coefficient maps, pre-
dicted the follow-up NPV with an average DICE coefficient of 0.71, outperforming the
DICE coefficient of 0.53 from the current standard of NPV obtained immediately after
the ablation treatment. The results show that noncontrast multiparametric MR imaging
can provide a more accurate prediction of treated tissue immediately after treatment.
Noncontrast assessment of MRgFUS procedures will potentially lead to more effica-
cious MRgFUS ablation treatments.
© 2019 The authors. All rights reserved.
1. Introduction
Minimally and noninvasive ablation therapies for treatment
of malignant tumors have become promising alternatives to sur-
gical resection. Ablation treatments are currently applied to
several benign indications, including prostate (Haider et al.,
2008; Rouvière et al., 2012; Kirkham et al., 2008), uterine
∗Corresponding author.
e-mail: blakez@sci.utah.edu (Blake Zimmerman)
fibroids (Stewart et al., 2003; Tempany et al., 2003; Hesley
et al., 2013), bone metastases (Gianfelice et al., 2008; Zaccagna
et al., 2015), liver (Leslie et al., 2008; Wijlemans et al., 2012),
and breast (Sabel et al., 2004; Merckel et al., 2013; Hectors
et al., 2016a). Magnetic-resonance-guided focused ultrasound
(MRgFUS) is a completely noninvasive ablation treatment. MR
provides excellent soft tissue contrast for treatment planning
and real-time temperature measurements during treatment. An
essential component of MRgFUS procedures is assessing the
treated tissue immediately after the procedure (Hectors et al.,
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2016b). MR biomarkers derived from MR imaging are used to
assess the extent of treated tissue. If untreated tumor is de-
tected, then additional ablation could be performed (Hectors
et al., 2016a).
The most common MR biomarker for assessing treated tis-
sue is the nonperfused volume (NPV) (Hectors et al., 2014,
2016b,a) that is identified on contrast-enhanced (CE) T1-
weighted (T1w) MR imaging. The NPV is characterized by
a lack of signal enhancement from impaired blood flow due to
vascular damage and coagulation from MRgFUS ablation (Hec-
tors et al., 2016a; Payne et al., 2013; Wijlemans et al., 2013;
McDannold et al., 2006). However, the NPV biomarker ob-
tained immediately after MRgFUS ablation treatment is not re-
liable for assessing the treated region due to adverse treatment
effects, such as edema, hyperemia, and increased vascular per-
meability that directly affect tissue perfusion (Hectors et al.,
2016b). Additionally, continuing treatment after CE imaging
could affect further treatment monitoring and trap toxic con-
trast agent in the tissue, prohibiting further MRgFUS treatment
if viable tumor is detected (Hectors et al., 2016b; Hijnen et al.,
2013a,b). There is a critical need for noncontrast MR biomark-
ers that can accurately assess treated tissue immediately after
treatment without inhibiting further MRgFUS ablation.
Several noncontrast, immediate MR biomarkers from mul-
tiparametric MR (MPMR) imaging have been investigated to
assess MRgFUS immediately after treatment, including T2w
images, MR temperature imaging (MRTI), and apparent diffu-
sion coefficient (ADC) maps (Hectors et al., 2014; Plata et al.,
2015; Mannelli et al., 2009; Haider et al., 2008; Wu et al.,
2006). These acute MR biomarkers are based on intrinsic tis-
sue properties that are sensitive to MRgFUS induced changes
(Hectors et al., 2016b). Prior work has shown that using acute
MPMR biomarkers could distinguish treated from untreated tis-
sue (Hectors et al., 2014). With a spatially accurate label of
nonviable tissue, machine learning could be used to identify
features within acute MPMR imaging to immediately predict
treatment outcomes. However, there is no accurate label of
nonviable tissue aligned with the immediate MPMR images to
enable such a study.
The NPV biomarker obtained during follow-up MR imaging
performed 3-5 days after MRgFUS treatment (follow-up NPV)
is an accurate label of nonviable tissue (Payne et al., 2013; Wi-
jlemans et al., 2013; Leslie et al., 2008). This follow-up NPV
could be used as label of nonviable tissue to facilitate learning
of MPMR biomarkers for immediate MRgFUS treatment as-
sessment. However, this follow-up NPV is not aligned with the
immediate MPMR biomarkers due to changes in patient pose,
positioning, and tissue deformation. Image registration is nec-
essary to account for changes in subject pose and positioning
to provide a spatially accurate label of nonviable tissue aligned
with treatment MPMR images. To our knowledge, deformable
image registration has not been applied to MRgFUS images to
align immediate MPMR biomarkers with the follow-up NPV.
Image registration has been an active research area for the
analysis of longitudinal imaging, and numerous image registra-
tion algorithms have been proposed in the literature (Zacharaki
et al., 2008; Wu et al., 2006; Ou et al., 2011; Li et al., 2009;
Brock et al., 2008, 2006; Ou et al., 2015; Jahani et al., 2018;
Sdika and Pelletier, 2009; Mencarelli et al., 2014; Castadot
et al., 2008). The volume of tissues such as muscle, fat, and
bone is preserved under normal physiological loading, such as
the changes in position and pose that can occur during multi-
ple imaging sessions (Humphrey, 2003). Therefore, image reg-
istration of MRgFUS MR images should preserve the volume
captured in the original image, which is critical when evaluat-
ing biomarkers used for treatment assessment. For MRgFUS
treatments, when deforming the follow-up NPV to be spatially
aligned with acutely obtained MPMR images, any deformation
that changes the volume of the follow-up NPV will directly
affect the learned prediction of the treatment outcome. Algo-
rithms presented in the literature regularize volume change dur-
ing registration, but they do not strictly enforce volume con-
servation (Ou et al., 2015; Jahani et al., 2018; Rohlfing et al.,
2003). A longitudinal registration method that enforces volume
conservation is needed to accurately model volume-preserving
tissue deformations, allowing for the accurate correction of
pose and positioning deformations that occur between follow-
up NPV and immediate MPMR images.
This work addresses these needs with two contribu-
tions: 1) AVOCADO: A VOlume Conserving Algorithm
for DiffeOmorphisms, a longitudinal registration pipeline
that computes a volume-preserving deformation to accu-
rately model biological tissue deformation, and 2) MPB-
CNN: MultiParametric Biomarker Convolutional Neural
Network, a deep learning model for predicting nonviable ver-
sus viable tissue from immediate MPMR imaging.
AVOCADO aligns the follow-up NPV with the immediate
MPMR images to yield a spatially accurate label of nonviable
tissue. The resulting label of nonviable tissue from AVOCADO
is used to train MPB-CNN to predict the nonviable tissue from
immediate MPMR images without contrast agent. These new
techniques are demonstrated using real data from a preclincal
animal model.
2. Study Design
A previously developed rabbit animal model was used to gen-
erate a data set with and without contrast biomarkers to compare
MPB-CNN against the clinical biomarker (NPV obtained im-
mediately after treatment) (Palussiere et al., 2003). The ablation
procedure and associated imaging protocol were designed to
capture MPMR and structural anatomical images (noncontrast
T1w) at distinct time points throughout the procedure. MPMR
images were acquired before, during, and after MRgFUS ab-
lation treatment to generate the immediate MPMR biomarker
images. CE T1w MR images were collected following the
MPMR imaging protocol at the end of the MRgFUS ablation
procedure and used to generate the clinical biomarkers. Fol-
lowing MRgFUS ablation, the animal recovered for 3-5 days
post-treatment, and follow-up imaging including the MPMR
protocol and CE T1w MR imaging was performed to gener-
ate the follow-up NPV label of nonviable tissue. The specifics
of the animal tumor model, ablation parameters, and image ac-
quisitions are described below. All procedures were approved
by the local Institutional Animal Care and Use Committee.
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Table 1: Table of parameters for the multiparametric scanning sequence used for ablation day and follow-up imaging. Coronal orientation was
used for all MR acquisitions. TR: Repetition Time, TE: Echo Time, EPI: Echo Planar Imaging, SPACE: Sampling Perfection with Application
Optimized Contrasts Using Different Flip Angle Evolution, VIBE: Volumetric Interpolated Breath-Hold, GRE: Gradient Recalled Echo, MRTI:
Magnetic Resonance Temperature Imaging, SS: Single Shot, SE: Spin Echo, and ETL: Echo Train Length. ∗ T1w sequence with contrast for NPV
segmentation. ∗∗ T1w sequence without contrast for image registration.
Scan
Type
Sequence TR (ms) TE (ms)
Flip
Angle
Field of
View (mm)
Pixel Bandwidth
(Hz/Pixel)
Acquisition
Resolution (mm)
Number
Averages
Acquisition Time
(mm:ss.ms)
MRTI
GRE-EPI
(ETL=7)
25 11 14◦ 192×150×20 750 1.5×1.5×2.0 1 00:04.50
T1w∗ VIBE 7.19 2.05 15◦ 256×192×52 250 1.0×1.0×1.0 1 1:03.00
T2w SPACE 2000 300 120◦ 256×192×52 700 1.0×1.0×1.0 2 5:12.00
T1w∗∗ VIBE 7.19 2.52 15◦ 256×192×56 250 0.5×0.5×1.0 3 6:19.00
Diffusion
SS-SE-EPI
(ETL=92)
(b=20,500)
7500 117 90◦ 160×116×20 1260 1.25×1.25×2.0 1 1:38.00
Fig. 1: The top row shows the positioning of the rabbit in the MR
bore and relative to the ultrasound transducer. The receiver MRI coil
in the table is shown in orange relative to the animal quadriceps. The
bottom row shows examples of the acquired T2 images with relation
to the overall setup. The colored arrows along each image indicate the
MR direction.
2.1. Animal Model and Hardware
A VX2 (5x106 cells in 50% media/Matrigel) cell suspen-
sion was injected intramuscularly into both quadriceps of New
Zealand white rabbits (N=8). On MRgFUS treatment day, the
animal was anesthetized with a ketamine injection and intu-
bated. Anesthesia was maintained with inhaled isoflurane (0.5-
5%). Under anesthesia, hair was removed via clippers and a
depilatory cream (Nair™) was applied to obtain an appropriate
acoustic window for treatment. Using a preclinical MRgFUS
system (Image Guided Therapy, Inc., Pessac, France), ablation
was performed on one tumor and surrounding muscle tissue
with a 256-element phased-array transducer (Imasonic, Voray-
sur-l’Ognon, France; 10-cm focal length, 14.4 x 9.8 cm aper-
ture, f=940 kHz) inside a 3T MRI scanner (PrismaFIT Siemens,
Erlangen, Germany). At 3-5 days post-treatment, the animal
was anesthetized and follow-up MR imaging was obtained (Ta-
ble 1). A depiction of the setup can be seen in Figure 1.
2.2. Ablation Parameters
Each animal received a mean of 11 sonications (range: 8-
14) during the MRgFUS ablation procedure, a mean acoustic
power of 47 W (range: 30-69 W), and an average sonication
duration of 31 seconds (range: 15-40 seconds), for an average
total output energy of 17,665 J (range: 11,563-26,004 J). All
ultrasound sonications were monitored in real time with a 3D
MRTI gradient echo sequence with a segmented echo planar
imaging readout (Table 1).
2.3. Image Acquisition
An in-house, single-loop MR receiver coil was incorporated
into the MRgFUS treatment table to improve the signal to noise
ratio (SNR) of the MR imaging (Figure 1). MPMR images were
acquired at three distinct time points: preablation, immediately
post-treatment, and 3-5 days post-treatment (follow-up). The
details of each scan collected at each time point are outlined
in Table 1. In addition to collecting a T1w image at each time
point without contrast, the same sequence was acquired imme-
diately ( 30 seconds) after administering gadolinium contrast
after ablation on treatment day and at the end of follow-up
imaging 3-5 days post-treatment. The CE T1w images were
collected to generate the NPV biomarker both immediately af-
ter and 3-5 days post-treatment. The NPVs were generated by
semiautomatic segmentation of the CE images and were vali-
dated by an expert radiologist (NW). The high-resolution T1w
image without contrast acquired at all time points depicts the
quadriceps anatomy without showing the tumor or ablated re-
gions and can therefore be used for registration without biasing
the registration with the tumor or ablated regions.
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3. Registration Methods
The registration methods used to align the follow-up NPV
with the MPMR images are described here. For the described
data set in section 2, the source image is the noncontrast T1w
MR image acquired during follow-up imaging, and the target
image is the noncontrast T1w MR image acquired immedi-
ately after the MRgFUS ablation procedure. Registration es-
timates a high-dimensional spatially smooth one-to-one and
onto transformation, or a diffeomorphism, that maps the lo-
cations from a source image to a target image, specifically:
φ : Ω ⊂ R3 → Ω. AVOCADO utilizes a multiscale gradient
flow that is driven first by discreet landmarks and then by image
intensity. Helmholtz-Hodge decomposition is used to guarantee
volume conservation. These sequential steps result in a volume-
preserving diffeomorphism that accurately maps the follow-up
NPV biomarker to the immediate MPMR images. This accurate
voxel-wise registration enables training MPB-CNN to generate
an immediate MPMR biomarker to assess the extent of MRg-
FUS ablation treatments without contrast imaging.
3.1. Gradient Flow
A multiscale algorithm was developed for generating a dif-
feomorphism that maps two anatomies based on the gradient
flow methodology previously used for general image registra-
tion problems (Christensen et al., 1996; Joshi and Miller, 2000;
Guo and Lu, 2006; Haker et al., 2004; Bauer et al., 2014). A
diffeomorphism is constructed in terms of solutions to the La-
grangian transport equation, defined via the ordinary differen-
tial equation (ODE)
dφ(~x, t)
dt
= v(φ(~x, t), t), φ(~x, 0) = ~x, t ∈ [0, 1] (1)
where ~x ∈ Ω is position, t is time, and v(·, ·) is a time-varying
velocity vector field. The diffeomorphism φ(·, ·) at time point t
is controlled by the velocity field v(·, ·) via the associated inte-
gral equation
φ(~x, t) = ~x +
∫ t
0
v
(
φ(~x, τ), τ
)
dτ, x ∈ Ω. (2)
If the velocity field is sufficiently well behaved (Younes, 2010;
Misiołek, 1993), φ(~x, t) is guaranteed to be a diffeomorphism.
The inverse diffeomorphism φ−1(~x, t) satisfies the Eulerian ODE
given by
dφ−1(~x, t)
dt
= −D
[
φ−1(~x, t)
]
v(φ−1(~x, t), t) (3)
where D [·] is the Jacobian. The above ODE can be approxi-
mately integrated via an implicit Euler method:
φ−1(~x, t + δt) = φ−1(x − δtv(~x, t), t) (4)
where δt is a scalar time step.
Using the transport equation above, a gradient flow is devel-
oped governed by forcing functions g(x, t). The forcing func-
tions are the gradient of an energy potential that defines the reg-
istration problem. A forcing function g(x, t) is related to the
velocity field via
Lv(φ(~x, t)) = g(φ(~x, t)) (5)
where L is a partial differential operator that has an associated
smoothing kernel K such that
v(φ(~x, t)) = Kg(φ(~x, t)). (6)
The operator K ensures the fields v(·, ·) are smooth and gives
sufficient differentiability for the existence and uniqueness of
the solution to the ODE, which guarantees that φ(~x, t) is a dif-
feomorphism (Joshi and Miller, 2000). Properties of the final
diffeomorphism can be controlled via the properties of v at ev-
ery time step.
3.2. Helmholtz-Hodge Decomposition
When deforming images of tissues such as fat, muscle, and
bone, the diffeomorphism mapping of the images should be
constrained to be volume preserving. Under normal physiolog-
ical tissue loading, soft tissues exhibit incompressible behavior
due to high water volume fractions (Humphrey, 2003). Enforc-
ing that the velocity fields v(·, ·) in Equation (2) describe incom-
pressible fluid flow ensures that the diffeomorphism is volume
preserving. Mathematically, incompressibility is equivalent to
ensuring the divergence of v(·, ·) is zero: ∇ · v(·, ·) = 0 (Hinkle
et al., 2012). According to the Helmholtz-Hodge decomposi-
tion, a smooth and rapidly decaying vector field can be uniquely
decomposed into an orthogonal sum of an irrotational, or curl-
free, vector field and a solenoidal, or divergence-free, vector
field (Bhatia et al., 2012). Uniquely decomposing the velocity
field v(·, ·) allows the calculation of the solenoidal component
by removing the irrotational component, which projects v(·, ·)
into the space of divergent-free vector fields (Cantarella et al.,
2002). By enforcing that each velocity field governing the ODE
in Equation (1) is divergent-free with the Helmholtz-Hodge de-
composition, the deformation is constrained to be volume pre-
serving and models realistic soft tissue deformation.
We implement the Helmholtz-Hodge decomposition and vec-
tor field projection of a discretized velocity field in the Fourier
domain. The Discrete Fourier Transform (DFT) for 1D central
difference gradient operator is given by
DFT
{ f (x + ∆x) − f (x − ∆x)
2∆x
}
=
i
2∆x
sin
(
ω
N
)
F(ω) (7)
where F(ω) = DFT { f (x)}, ∆x is the spacing of the samples, ω
is angular frequency, and N is the number of samples. Expand-
ing the DFT of the discrete gradient operator to 3D yields
W(~ω) =
i
2

1
∆x sin
(
ωx
Nx
)
1
∆y sin
(
ωy
Ny
)
1
∆z sin
(
ωz
Nz
)
 . (8)
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The divergence of a vector field Fv is given by
Fdiv v(~ω) =
W(~ω) · Fv(~ω)∥∥∥W(~ω)∥∥∥ . (9)
A vector field is projected to the space of solenoidal vector
fields by removing the curl-free component:
Fcurl v(~ω) = Fv(~ω) −
W(~ω) · Fv(~ω)∥∥∥W(~ω)∥∥∥
 W(~ω)∥∥∥W(~ω)∥∥∥ . (10)
The inverse DFT of Fcurl v(~ω) gives a divergent-free velocity
field v(·, ·) for solving Equation (1). Controlling the divergence
of the velocity field at every iteration generates a final diffeo-
morphism with physiologically expected incompressibility.
An example of registration both with and without incom-
pressibility can be seen in Fig. 2. The top row shows the source
and target images and their respective starting areas (A) in units
of pixels (px). The middle row shows the result of registra-
tion without projecting the velocity field v(·, ·) to the space of
divergent-free velocity fields. The area of the source object re-
duced by 32.87% to almost exactly match the target area. How-
ever, if the ellipse was a biological tissue, then the area should
remain constant through registration because tissues are incom-
pressible. The bottom row shows the volume-preserving result
of registration with projecting the velocity field v(·, ·) to the
space of divergent-free velocity fields. The volume-preserving
method generates deformations that reflect the incompressibil-
ity of biological tissues.
3.3. Rigid Registration
In the outlined study design, it was impossible to exactly
replicate subject pose between treatment and follow-up imag-
ing. For large changes in the subject pose, AVOCADO reg-
istration begins with a landmark registration problem based
on user-defined source and target anatomical landmarks se-
lected in follow-up and treatment-day coordinates, respec-
tively. Anatomical landmarks are used to estimate a volume-
preserving rigid transformation in two steps. First, an affine
transformation A is estimated via a least squares minimization:
A =
(
~ci~p
T
i
) (
~pi~p
T
i
)−1
(11)
where ~pi are the source landmarks and ~ci are the target land-
marks. Second, the affine transformation is projected to a rigid
transformation R via the singular value decomposition of the
matrix A (Van Loan and Golub, 1983).
3.4. Landmark-Driven Gradient Flow
Given the rigid transformation R, an anatomical landmark-
driven higher dimensional transformation is estimated by using
gradient flow on an energy potential g(x) = ERBF , from Equa-
tion (5), which is a function only of the landmark points:
ERBF =
M∑
i=1
∥∥∥R~pi − φ−1(~ci, t)∥∥∥2 (12)
A = 1888.00 px
Source Image
φ
↼−−−−⇁
φ−1
A = 1264.00 px
Target Image
A = 1267.44 px 2.0
1.0
0.0
A = 1887.36 px
I(φ−1) Image φ−1 Field |Dφ−1|
2.0
1.0
0.0
Fig. 2: Example of non-volume-preserving versus volume-preserving
gradient flow registration. The top row shows the source and tar-
get image with their respective areas (A) in pixels. The middle and
bottom rows from left to right show the deformed image, deforma-
tion field, and Jacobian determinant for non-volume-preserving and
volume-preserving registration, respectively. Both registrations were
run to convergence using an energy change of 1 × 10−3 as a conver-
gence point.
where M is the number of landmark pairs and φ−1(·, t) is the
inverse diffeomorphism at time t. A multiquadratic radial basis
function (RBF) is used as the smoothing operator K:
K(~r) =
√
1 +
(
 ~r
)2, ~r = ~x − ~c (13)
where  is a shape-tuning parameter, set to  = 1.0 for all ex-
periments in this work. Although thin plate splines is com-
monly used, it is ill-conditioned without an affine transforma-
tion. However, an affine transformation is not volume pre-
serving. The velocity field v(·, ·) is expressed as a summation
of weighted RBF fields. Given the distance d between points
~di = Rpi − φ−1(~ci, t), the weights b are solved via
b1(t)
...
bi(t)
 =

K(~r11) . . . K(~r1 j)
...
. . .
...
K(~ri1) . . . K(~ri j)

−1 
~d1(t)
...
~di(t)
 (14)
with ~ri j = φ−1(~ci, t) − φ−1(~c j, t) (Buhmann, 2003). The velocity
field is given by
v(~x, t) =
M∑
i=1
bi(t)K
(∥∥∥R~x − ~ci∥∥∥) (15)
The vector field v(~x, t) is subsequently projected into the
space of divergent-free vectors fields via the Helmholtz-Hodge
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decomposition described in section 3.2. For a given time step,
the diffeomorphism φ−1 is updated via
φ−1(~x, t + δt) = φ−1(x − δtv(~x, t), t) (16)
where δt is a scalar step size. For a given time step, we up-
date the diffeomorphism according to Equation 4 until a con-
vergence criterion is met. For matching landmarks, the conver-
gence point is when the ERBF becomes less than the average
inter-user variability (u) of selecting the landmarks, which is
determined from the test-retest capability of users when select-
ing the source anatomical landmarks (section 4.3).
3.5. Image Intensity-Driven Gradient Flow
The final registration step is an image registration problem
to match two anatomies based on image similarities of a source
and target image. The image intensity-driven gradient flow is
initialized with the diffeomorphism from landmark driven gra-
dient flow. The energy potential EImage for the image registra-
tion problem is
EImage =
∫
Ω
∥∥∥I1(φ−1(~x, t)) − I0(~x)∥∥∥2 (17)
where I1 is the source image (follow-up, noncontrast T1w VIBE
image) and I0 is the target image (treatment-day, noncontrast
T1w VIBE image). The associated forcing function from Equa-
tion (5) is given by
g(~x, t) =
(
I1(φ−1(~x, t)) − I0(~x)
)
∇I1(φ−1(~x, t)) (18)
where ∇ is the gradient operator.
An operator of the Cauchy-Navier type is chosen for the L
operator from Equation (5) with L = −α∆ + γI, where ∆ is
the Laplace operator and I is the identity operator. The scalars
α and γ control smoothness and ensure the operator is non-
singular, respectively. This operator has been used previously
in image registration (Beg et al., 2005). The smoothing ker-
nel associated with L is applied in the Fourier domain with
DFT{K} = DFT{L}−1 to get v(x, t). The smoothed vector field
is projected into the space of divergent-free vector fields using
the Helmholtz-Hodge decomposition described in section 3.2.
For a given time step, the diffeomorphism is updated according
to Equation (4). The intensity-based registration continues until
the change in energy EImage in Equation (17) from the previous
iteration is less than I = 3 × 10−4.
In total, the final diffeomorphism defined by AVOCADO is
the composition of the rigid transformation, the gradient flow
on anatomical landmarks, and the gradient flow on the image
intensities. An outline of the final algorithm can be seen in
Figure 3. This volume-preserving method ensures that regis-
tration process does not bias the volume of the follow-up NPV
biomarker.
4. Registration Validation
This section describes the methods to assess different as-
pects of the AVOCADO algorithm, including changes in the
1: procedure AVOCADO( pi, ci, I0, I1, δt )
2: Solve affine A =
(
ci p
T
i
) (
pi p
T
i
)−1
3: Singular Value Decomposition A 7→ R
4: φ−1RBF(~x, k = 0) := ~x
5: while ERBF ≥ u, k = k + 1 do
6: Solve spline weights b = K−1d
7: v(~x, k) =
∑M
i=1 biK
(∥∥∥R~x − φ−1(~ci, k)∥∥∥)
8: Project div-free δtv(~x, k) 7→ s(~x, k)
9: φ−1RBF(~x, k + 1) = φ
−1
RBF(~x − s(~x, k), k)
10: end while
11: φ−1I (~x, k = 0) = φ
−1
RBF(~x, k)
12: while |EImage(k − 1) − EImage(k)| ≤ I do
13: g(~x, k) =
(
I1(φ−1I (~x, k)) − I0
)
∇I1(φ−1I (~x, k))
14: v(~x, k) = DFT−1
{
DFT {L}−1DFT {g(~x, k)}
}
15: Project div-free δtv(~x, k) 7→ s(~x, k)
16: φ−1I (~x, k + 1) = φ
−1
I (~x − s(~x, k), k)
17: end while
18: return φ−1I (~x, k)
19: end procedure
Fig. 3: AVOCADO algorithm to calculate the diffeomorphism φ−1(~x)
mapping two anatomies I1 and I0 while preserving volume.
user-dependent inputs, volume conservation capabilities, and
the overall landmark-based registration accuracy. This assessed
accuracy is compared to another registration method as well.
4.1. Changes in User-Dependent Inputs
Model evaluation with known changes to the user inputs was
performed to determine the effect on volume change and reg-
istration accuracy. The only adjustable input parameter to the
AVOCADO algorithm is the scalar step size δt in Equation (4).
The algorithm was executed with multiple step sizes to deter-
mine the optimal step size that simultaneously minimizes vol-
ume change and landmark target registration error (TRE). After
determining the optimal step size, different aspects of the model
were tested while keeping the step size constant.
In addition to the user input step size, AVOCADO is de-
pendent on the input anatomical landmarks. Due to manual
user selection, there is an expected variance in the initializa-
tion landmarks introduced from the user’s capability of select-
ing the anatomical landmarks. The robustness of AVOCADO to
changes in the input landmarks was tested by applying a range
of zero mean, normally distributed perturbations to each source
landmark individually and executing the registration with the
updated landmarks. Changes less than the re-test capability
of the observers (intraobserver error) should not change the fi-
nal registration accuracy. If perturbations below the intraob-
server error do not change the final accuracy, then AVOCADO
is sufficiently robust to variance introduced from user-selected
anatomical landmarks.
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4.2. Volume Preservation Capability
Transformations produced from AVOCADO should preserve
volume when applied to follow-up MR imaging. The volume
preservation capability of our model was validated using expert
segmentations of the NPV biomarker on follow-up MR imaging
(Rohlfing et al., 2003). The volume was calculated by integrat-
ing the binary segmentation and scaling by the product of the
voxel spacing. The estimated deformation was then applied to
the follow-up NPV segmented images to register them with the
MR images obtained immediately after MRgFUS ablation. The
segmentation volume before and after deformation was calcu-
lated and compared to determine the final volume change for
each subject. A volume change of less than 0.5% was assumed
to adequately preserve volume.
4.3. Landmark-Based Registration Accuracy
The overall accuracy of AVOCADO will be evaluated using
manually selected anatomical landmarks. Multiple observers
(N=3) were given anatomical landmarks in the target images
and asked to find the corresponding landmarks in the source im-
ages using 3D Slicer software (Fedorov et al., 2012). A total of
10 source and target landmark pairs were chosen for each sub-
ject over the entire region of interest. Given the multiparametric
images acquired, landmarks that are not visible in the registra-
tion images are selected to evaluate the registration in homo-
geneous tissue regions. Half (N=5) of the landmarks were not
visible in the registration volumes. Examples of the validation
landmarks can be seen in Figure 4. The TRE was calculated
by deforming anatomical landmarks with the estimated defor-
mation and computing the Euclidean distance between the de-
formed point and its corresponding target landmark. The land-
marks for validation were chosen independently from the RBF
initialization landmarks.
The landmark-based accuracy of AVOCADO was compared
with another registration algorithm to demonstrate the over-
(a) (b)
(c) (d)
Fig. 4: Example validation landmarks: (a) and (b) show a correspond-
ing blood vessel bifurcation in the treatment and follow-up CE images,
respectively, that was not visible during registration; and (c) and (d)
show a corresponding bone structure in the treatment and follow-up
images, respectively, that was visible during registration.
all accuracy of AVOCADO. Deformable Registration via At-
tribute Matching and Mutual-Saliency Weighting (DRAMMS)
has been shown to consistently outperform other registration
methods and is often used for longitudinal registration (Ou
et al., 2011, 2014, 2015, 2012). DRAMMS was executed on
the same images with default input parameters. If the initial-
ization step of DRAMMS, automated affine registration, re-
turned a warning, then the input images to DRAMMS were
matched with an affine derived from the user-defined anatom-
ical landmarks for AVOCADO. The resulting volume change
and the TRE were computed to compare with AVOCADO. A
two-sample-related t-test on the Euclidean error between de-
formed and target landmarks was used to test for a significant
difference between AVOCADO and DRAMMS.
Finally, the error due to user variability when manually se-
lecting anatomical landmarks was evaluated. Multiple ob-
servers selected validation landmarks, and each observer was
asked to repeat their landmark selection. The inter and intraob-
server variations are calculated by comparing the Euclidean dis-
tance between selected landmarks both across observers and
within a single observer, respectively. A two-sample-related t-
test between interobserver and intraobserver errors was used to
test for significance difference between the same observer and
across observers.
5. Mulitparametric Biomarker CNN
The input data for the MPB-CNN are the pre- and post-
MRgFUS ablation MPMR images described in Table 1. The
label was the follow-up NPV registered with the treatment-day
MPMR images according the AVOCADO algorithm. The ob-
jective was to train the MPB-CNN to predict the nonviable tis-
sue using only noncontrast MPMR images acquired pre- and
post-MRgFUS ablation. The performance of the MPB-CNN
was evaluated by comparing the prediction with the treatment-
day NPV, which is the clinical prediction of nonviable tissue.
The network was considered successful if its prediction of the
nonviable tissue was as accurate or more accurate than the treat-
ment-day NPV as measured by the DICE coefficient (Dice,
1945). The data set, preprocessing, and neural network archi-
tecture for deep learning MR biomarkers are described here.
5.1. Data Set and Preprocessing
The training data for MPB-CNN was selected from the re-
sults of AVOCADO registration between immediate MPMR
and follow-up images. Two subjects were excluded from the
MPB-CNN set due to small follow-up NPV volumes. Each
acute MR image was resampled with linear interpolation onto
a common grid with 0.5 mm isotropic resolution to accommo-
date the subset of immediate MPMR images acquired at lower
resolutions. The ground truth/target label for each subject was
the expert segmentation of the follow-up NPV deformed with
the subject-specific diffeomorphism from AVOCADO, which
results in a common grid for all of the real-time MR images
and target images for each subject.
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The six input MR images to the network were: (1) pre-
and (2) postablation T2w images, (3) pre- and (4) postabla-
tion apparent diffusion coefficient (ADC) maps, (5) cumula-
tive thermal dose (CTD) map, and (6) maximum temperature
projection (MTP) map, derived from MR temperature imag-
ing. The ADC maps were calculated from diffusion weighted
imaging using MRI vendor’s proprietary image reconstruction
pipeline (Siemens, Erlangen, Germany). The CTD maps were
calculated from MRTI using the equivalent number of minutes
of heating at 43 °C equation commonly used in the literature
(Van Rhoon et al., 2013; Dewhirst et al., 2003). The MTP maps
were the highest temperature in °C recorded for each pixel from
the MRTI over time (using a rectal probe for starting tempera-
ture).
All images were cropped to a 128 × 128 × 90 region cen-
tered on the registered follow-up NPV segmentation, and image
intensities were normalized using the average maximum from
that image type across all subjects (e.g. the average maximum
ADC map value across all subjects is used to normalize all the
ADC maps, etc.). The volumes were sliced coronally to gener-
ate 128× 128 2D images for the network input. This data set of
540 images was split 90% for training and 10% for validation:
A slab of nine consecutive slices is extracted from each subject
and excluded from the training set. Each slab was positioned
such that it contains ablated regions. The network was trained
using [128 × 128] randomly sampled coronal images, exclud-
ing the slabs for validation. Each input batch was augmented
with: 1) 0-10% random changes in the brightness, contrast, and
saturation; 2) random horizontal and vertical flips; 3) random
rotations of 0-20 degrees; and 4) zero mean Gaussian noise.
5.2. Network Architecture
A U-Net segmentation architecture was used for the MPB-
CNN with six input channels (Ronneberger et al., 2015). The
network returned a pixel-wise probability of the tissue viability,
and the output of the network was evaluated against the follow-
up NPV segmentation using a binary cross entropy loss func-
tion. The network was validated with the central slice from
each validation slab. When evaluating the network, the prob-
ability output from the network was thresholded at a value of
0.5 to yield a segmentation of viable versus nonviable tissue.
The purpose of the MPB-CNN was to provide a more accurate
and immediate prediction of treated tissue than the treatment-
day NPV biomarker without using CE imaging. Comparison of
MPB-CNN biomarker with the treatment day NPV biomarker
was computed by the DICE coefficient between each MPB-
CNN prediction against the follow-up NPV segmentation.
6. Results
The overall goal of registration was to align the follow-up
NPV with the acute MR imaging obtained immediately after
MRgFUS ablation. Figure 5 shows the registration at the dif-
ferent registration steps for subject 8 from the accumulation
steps described in section 3.3 through section 3.5. The left col-
umn shows the target and source CE T1w images at the acute
and follow-up time points, respectively. Images (a)-(d) show
Table 2: Volumes and changes from non-volume-preserving
(DRAMMS) and volume-preserving (AVOCADO) registration. A
negative percent means a reduction in the final volume.
Original DRAMMS AVOCADO
Subj. Vol mm3 Vol mm3 % Vol mm3 %
1 1334.75 905.31 −32.17 1339.66 0.37
2 38.00 55.77 46.76 38.13 0.34
3 915.38 903.44 −1.30 911.82 −0.39
4 161.00 145.09 −9.88 161.57 0.36
5 20.38 12.61 −38.11 20.42 0.22
6 1949.15 1614.37 −17.18 1955.99 0.35
7 2628.12 3268.78 24.38 2629.99 0.07
8 3959.38 3878.74 −2.04 3966.28 0.17
the correlation of the acute (blue line) and follow-up (red line)
NPV time points with accumulating registration steps, with (a)
original scanner coordinates, (b) rigid registration, (c) RBF reg-
istration, and (d) intensity-based registration. The background
image in (a)-(d) is the acute CE T1w image, or the target image.
There is increasing correlation between the shape and location
of the two contours the as registration steps proceed.
6.1. User-Dependent Model Inputs
The plot of step size versus both the mean volume change
and the mean TRE can be seen in Figure 6 where the shaded
areas depict the standard deviation. All volume changes under
0.5% were attributed to discretization and interpolation error.
The optimal step size was determined to be δt = 0.0316, which
minimized the TRE and had volume changes under the 0.5%
error threshold. If the step size was too small, the algorithm
converged before fully matching the images. This optimal step
size was used for all other results. Figure 7 shows the results of
perturbing the RBF initialization landmarks. For perturbations
under the average user-repeatability (intraobserver) error, there
was minimal change in the final TRE. As expected, if the per-
turbations became large (> 2mm) the final TRE also increased.
6.2. Volume Preservation
The original volumes, deformed volumes, and the percent
change for both the non-volume-preserving (DRAMMS) and
volume-preserving (AVOCADO) registration methods are re-
ported in Table 2. The original volume of the expert NPV
biomarker segmented on follow-up CE T1w MR imaging
ranged from 0.02 ml to 3.96 ml (mean ± STD = 1.34 ± 1.39
ml). The absolute volume change after registration with AV-
OCADO ranged from 0.07% to 0.39% (0.28 ± 0.11%). All
volume changes for AVOCADO are under our 0.5% threshold
for discretization or interpolation error.
In every subject, registration with DRAMMS caused a larger
change in the follow-up NPV segmentation volume when com-
pared to the AVACADO results. The average absolute vol-
ume change of the NPV biomarker due to registration with
DRAMMS ranged from 1.30% to 46.76% (21.48 ± 16.80 %).
DRAMMS registration resulted in both increased or decreased
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Source (a) (b)
Target (c) (d)
Fig. 5: Registration example for subject 8. The left column shows the expert NPV contours over the CE T1w images for the source and target
images: (a)-(d) show the progression of the registration starting with (a) original scanner coordinates; (b) rigid registration; (c) RBF registration;
and (d) intensity-based registration.
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Fig. 6: Plot of the mean volume change and mean TRE across all sub-
jects relative to step size δt. The optimal step size for minimizing vol-
ume change and TRE simultaneously can be seen as δt = 0.0316.
NPV biomarker volume, with the largest increase of 46.47%
and the largest decrease of 38.11%. However, the extremes of
volume change with DRAMMS occurred with relatively small
original volumes. Figure 8 shows an example of the difference
in volume between DRAMMS registration and AVOCADO
registration for subject 7.
6.3. Registration Accuracy
The intra- and interobserver errors are plotted in Figure 9.
The intraobserver variability over the eight rabbits ranged from
0.82 mm to 1.22 mm (0.93 ± 0.13 mm). The interobserver vari-
ability ranged from 0.65 mm to 1.26 mm (0.89 ± 0.18 mm).
There was no significant difference between the interobserver
and intraobserver errors with a two-sample-related t-test p value
of p = 0.95.
The final TRE for DRAMMS and AVOCADO are plotted in
Figure 10. For the eight rabbits analyzed in this study, the final
TRE for AVOCADO ranged from 1.08 mm to 1.60 mm (1.33 ±
0.16 mm). For DRAMMS, the final TRE ranged from 1.07 mm
to 2.78 mm (1.69 ± 0.64 mm). An example of the deformations
produced from DRAMMS and AVOCADO can be seen in Fig-
ure 11. The deformations φ−1 from AVOCADO are smoother
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Fig. 7: Mean anatomical perturbation across all subjects plotted ver-
sus the final mean TRE of the registration. The mean intraobserver
variability for selecting anatomical landmarks is 0.93mm.
than from DRAMMS, and the Jacobian determinant for AVO-
CADO is 1 over the entire volume. Even though AVOCADO
was constrained to be volume preserving (Figure 11), the TRE
for AVOCADO was significantly lower than DRAMMS with a
two-sample-related t-test p value of p = 0.018.
6.4. MPB-CNN
An example of the prediction from the biomarker CNN on
one of the validation images is shown in Figure 12. Images (a)-
(d) show the six input channels to the network with the regis-
tered follow-up NPV contour overlaid in red. The bottom image
(g) shows the prediction using acute NPV (green contour) ver-
sus using the trained biomarker CNN (blue contour) against the
follow-up NPV (red contour). The network yields a more ac-
curate prediction of the final treated tissue than the acute NPV.
The DICE coefficient of the acute NPV prediction compared
with the follow-up NPV over all validation images ranged from
0.00 to 0.83 (0.53 ± 0.30), whereas the DICE coefficient of the
MPB-CNN prediction compared with the follow-up NPV over
all validation images ranged from 0.30 to 0.86 (0.71 ± 0.20).
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(a) (b)
Fig. 8: Subject 7 example illustrating the volume difference between
DRAMMS (green) and AVOCADO (purple) registration. (a) A vol-
ume rendering of the NPV segmentations registered using DRAMMS
and AVOCADO shows the spatial differences between the registration
methods. (b) A slice from the acute CE T1w image with an overlay of
contours of the segmentations registered using DRAMMS and AVO-
CADO.
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Fig. 9: Plot of the intraobserver and interobserver errors in selecting
source anatomical landmarks.
7. Discussion
One of the many challenges of MRgFUS longitudinal regis-
tration is the lack of a gold-standard target image due to bio-
logical changes that occur over time. Consequently, any regis-
tration method should not be biased by biological changes but
based on time-invariant anatomy, such as skin boundaries and
bone. Any registration method used should also preserve the
volume of source images to model true deformation of biologi-
cal tissues. Even with the volume constraint, registration using
AVOCADO can still successfully register two time points of the
same anatomy.
Traditional registration methods can cause volume change
during registration, as shown in Table 2. Even though the
ablation volume was not visible in the registration volumes,
DRAMMS still caused volume changes. The effect that volume
preservation can have on the final result can be seen in Fig-
ure 8. Registration without volume preservation can alter the
final size of the follow-up NPV. If the volume of the follow-up
NPV was increased or decreased during registration, the MPB-
CNN would be trained to similarly over- or underestimate the
nonviable tissue. However, because AVOCADO constrains vol-
ume change, the original volume of the follow-up NPV did not
change after applying the diffeomorphism. This is a particular
advantage because tissues do not change volume during defor-
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Fig. 10: Plot of the TRE for both non-volume-preserving (DRAMMS)
and volume-preserving (AVOCADO) registration methods.
mation, and the MPB-CNN is trained against the nonviable tis-
sue from follow-up NPV, which is a more accurate description
of the true treatment outcome.
Even though AVOCADO preserves volume, the accuracy of
registration is significantly better than DRAMMS (Figure 10).
Despite the potential volume increase from adverse treatment
effects, the TRE results indicate that this volume change is neg-
ligible, suggesting that, for the amount of volume treated in
this study, volume change during registration is not necessary
to successfully register immediate MPMR biomarkers with the
follow-up NPV. More importantly, the volume change from de-
formation of follow-up NPV images will have minimal influ-
ence on the MPB-CNN predictions. This is an imperative re-
sult because inherent biological volume changes in the follow-
up NPV are preserved through the AVOCADO pipeline. Al-
though volume changes from adverse treatment effects in this
study were negligible, treating larger targets with MRgFUS
may cause larger changes in volume and affect the registration
accuracy of AVOCADO.
There are still several challenges for longitudinal registration
of MRgFUS images. In this study, the water used for acous-
tic coupling to the quadriceps creates a large homogeneous in-
tensity on the MR images, with a total water volume typically
larger than the quadriceps volume, which caused automatic
affine registration to favor matching the water signal as op-
posed to the quadriceps. In fact, when running registration with
DRAMMS, the program returned an warning suggesting that
it was not confident in the automatic affine registration results.
Consequently, DRAMMS was run on images that were already
registered with an affine solved from the anatomical-registration
landmarks used in AVOCADO. Future studies could use a MR
contrast agent to alter the T1 signal from the water to provide in-
creased contrast between the muscle and coupling agent (Poor-
man et al., 2019; Zhang et al., 1992; de Bever et al., 2016). Ad-
ditionally, due to the rabbit being positioned on its side, the de-
lineation between bladder and the quadriceps was often unclear,
which made registration of just the quadriceps difficult. Al-
though there were several registration challenges with the rab-
bit model, MRgFUS ablation therapies are being investigated
in application to other anatomies, including breast, brain, and
prostate. With other anatomies, challenges (such as the delin-
Blake Zimmerman et al. / Preprint (2019) 11
D
R
A
M
M
S
2.0
1.0
0.0
Deformed Image φ−1 Field Jacobian Determinant
AV
O
C
A
D
O
2.0
1.0
0.0
Fig. 11: Subject-specific example (subject 7) of non-volume-preserving registration (DRAMMS top row) and volume-preserving registration
(AVOCADO bottom row). Note the smoothness of the field and the homogeneity of Jacobian determinant for the volume-preserving registration.
(a) (b)
(c) (d)
(e) (f)
(g)
Fig. 12: CNN prediction example for subject 7. Normalized input
parameters to the network include: (a) pre-T2w, (b) post-T2w, (c) pre-
ADC map, (d) post-ADC map, (e) CTD map, and (f) MTP map. The
red line on each input parameter shows the registered follow-up NPV
contour. (g) The follow-up NPV contour (red), the acute NPV predic-
tion (green), and the CNN prediction (blue).
eation between bladder and quadriceps) will not affect the reg-
istration; however, similar anatomy-specific issues may require
individual attention.
Despite these limitations, AVOCADO demonstrated that reg-
istration with volume conservation does not inhibit the accuracy
of registration. In this work it was applied to the MRgFUS
data to facilitate deep learning MPMR biomarkers for MRg-
FUS treatment assessment with a voxel-wise label of nonviable
tissue Whereas this study evaluated on a MRgFUS data set,
the registration performed is generalizable to other longitudinal
imaging studies with both therapeutic and diagnostic implica-
tions.
The results of MPB-CNN show the potential for immediate,
noncontrast, multiparametric MR biomarkers to more reliably
assess MRgFUS treated tissue than the clinical NPV biomarker.
For the data collected, the MPB-CNN was able to better predict
the treated tissue seen on follow-up imaging when compared
with the treatment-day NPV biomarker obtained using CE T1w
imaging. This prediction could likely be improved with addi-
tional MR parameters such as quantitative T1 or T2 mapping or
other techniques. Additionally, the total MR acquisition time of
the MPMR images was only 5.5 minutes, which is well within
expected time limits for an assessment protocol (Hectors et al.,
2016b).
Although this initial MPB-CNN study presents promising re-
sults, there are still limitations. Obtaining data for a single sub-
ject to train the network is cumbersome and expensive. The
data presented here allowed us to train a 2D neural network,
but more subjects would allow us to train a 3D network and
obtain a volumetric prediction of the treated tissue. Additional
data would also allow for training more accurate and general-
izable models. However, this work demonstrates that a CNN
approach can provide more accurate measures of the treated tis-
sue. Although the MPB-CNN is trained against follow-up NPV,
the gold standard for assessing treated tissue is histopathology.
Although some studies have attempted MR to histopathology
registration, this process is very limited and difficult. Compar-
ing immediate MPMR biomarkers with the follow-up NPV is
a necessary intermediate step toward defining new immediate
MPMR biomarkers for treatment assessment.
Future work will include better understanding of the MPB-
CNN and what input features are most indicative of treated tis-
sue. By understanding the network weights, the underlying in-
trinsic tissue property that is the best indicator of tissue via-
bility could be determined. Gaining this insight will allow the
design of a more targeted MR protocol and modify the network
inputs to maximize the predictive power of the MPB-CNN. Al-
though the presented registration has been applied to a specific
animal model and data, the methods can be expanded to investi-
gate and improve other minimally and noninvasive MR guided
treatments.
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